{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:23:53Z","timestamp":1785335033976,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T00:00:00Z","timestamp":1348012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10928-012-9271-3","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T12:38:34Z","timestamp":1347971914000},"page":"601-618","source":"Crossref","is-referenced-by-count":26,"title":["Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database"],"prefix":"10.1007","volume":"39","author":[{"given":"K.","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Hutmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. W.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,19]]},"reference":[{"key":"9271_CR1","volume-title":"Pharmacometrics: the science of quantitative pharmacology","author":"DR Mould","year":"2006","unstructured":"Mould DR (2006) Developing models of disease progression. In: Ette EI, Williams PJ (eds) Pharmacometrics: the science of quantitative pharmacology. John Wiley & Sons, Inc, Hoboken. doi: 10.1002\/9780470087978.ch21"},{"key":"9271_CR2","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.89.23.11466","volume":"89","author":"NH Holford","year":"1992","unstructured":"Holford NH, Peace KE (1992) Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proc Natl Acad Sci USA 89:11466\u201311470","journal-title":"Proc Natl Acad Sci USA"},{"key":"9271_CR3","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1073\/pnas.89.23.11471","volume":"89","author":"NH Holford","year":"1992","unstructured":"Holford NH, Peace KE (1992) Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proc Natl Acad Sci USA 89:11471\u201311475","journal-title":"Proc Natl Acad Sci USA"},{"key":"9271_CR4","first-page":"17","volume":"47","author":"NH Holford","year":"1994","unstructured":"Holford NH, Peace KE (1994) The effect of tacrine and lecithin in Alzheimer\u2019s disease. A population pharmacodynamic analysis of five clinical trials. Eur J Clin Pharmacol 47:17\u201323","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"9271_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jalz.2009.05.665","volume":"6","author":"K Ito","year":"2010","unstructured":"Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, Tensfeldt T, Alzheimer\u2019s Disease Working Group (2010) A disease progression meta-analysis model in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 6(1):39\u201353","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"9271_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jalz.2010.03.018","volume":"7","author":"K Ito","year":"2011","unstructured":"Ito K, Corrigan B, Zhao Q, French J, Miller R et al (2011) Disease progression model for cognitive deterioration from ADNI database. Alzheimer\u2019s Dementia 7(2):151\u2013160","journal-title":"Alzheimer\u2019s Dementia"},{"key":"9271_CR7","unstructured":"William-Faltaos D, Chen Y, Wang, Y, Gobburu J, Zhu H (2011) Quantification of disease progression and drop-out for Alzheimer\u2019s Disease. Division of Pharmacometrics, Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA"},{"key":"9271_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0091270011405497","volume":"52","author":"MN Samtani","year":"2012","unstructured":"Samtani MN, Farnum M, Lobanov V, Yang E, Raghavan N, DiBernardo A, Narayan V, Alzheimer\u2019s Disease Neuroimaging initiative (2012) An Improved model for disease progression in patients from the Alzheimer\u2019s disease neuroimaging initiative. J Clin Pharmacol 52:629\u2013644","journal-title":"J Clin Pharmacol"},{"key":"9271_CR9","doi-asserted-by":"crossref","unstructured":"Rogers JA, Polhamus D, Gillespie WR, Ito K, Romero K et al (2012) Combining patient-level and summary-level data for Alzheimer\u2019s disease modeling and simulation: a beta regression meta-analysis. J Pharmacokinet Pharmacodyn. doi: 10.1007\/s10928-012-9263-3","DOI":"10.1007\/s10928-012-9263-3"},{"key":"9271_CR10","unstructured":"Jacob Brogren (2011) Separate vs simultaneous analysis of co-primary endpoints in Alzheimer\u2019s disease clinical trials. In: Annual meeting of the population approach group in Europe (PAGE). ISSN 1871-6032 PAGE 21, Abstr 2038, www.page-meeting.org\/?abstract=2038"},{"issue":"3","key":"9271_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S (1982) Measurement of functional activities in older adults in the community. J Gerontol 37(3):323\u2013329","journal-title":"J Gerontol"},{"issue":"7","key":"9271_CR12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s11095-005-5641-5","volume":"22","author":"TM Post","year":"2005","unstructured":"Post TM, Freijer JI, DeJongh J, Danhof M (2005) Disease system analysis: basic disease progression models in degenerative disease. Pharm Res 22(7):1038\u20131049","journal-title":"Pharm Res"},{"issue":"2","key":"9271_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","volume":"7","author":"Alzheimer\u2019s Association","year":"2011","unstructured":"Association Alzheimer\u2019s (2011) Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dementia 7(2):208\u2013244","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"6","key":"9271_CR14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneurol.2010.115","volume":"67","author":"SE O\u2019Bryant","year":"2010","unstructured":"O\u2019Bryant SE, Lacritz LH, Hall J, Waring SC, Chan W et al (2010) Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer\u2019s coordinating center database. Arch Neurol 67(6):746\u2013749","journal-title":"Arch Neurol"},{"key":"9271_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-001-0067-1","volume":"3","author":"JW Ashford","year":"2001","unstructured":"Ashford JW, Schmitt FA (2001) Modeling the time-course of Alzheimer dementia. Curr Psychiatry Rep 3:20\u201328","journal-title":"Curr Psychiatry Rep"},{"key":"9271_CR16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","volume":"70","author":"M Jucker","year":"2011","unstructured":"Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532\u2013540","journal-title":"Ann Neurol"},{"issue":"9","key":"9271_CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/sim.4155","volume":"30","author":"MM Hutmacher","year":"2011","unstructured":"Hutmacher MM, French JL, Krishnaswami S, Menon S (2011) Estimating transformations for repeated measures modeling of continuous bounded outcome data. Stat Med 30(9):935\u2013949","journal-title":"Stat Med"},{"issue":"4","key":"9271_CR18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","volume":"35","author":"JE Ahn","year":"2008","unstructured":"Ahn JE, Karlsson MO, Dunne A, Ludden TM (2008) Likelihood based approaches to handling data below the quantification limit using NONMEM VI. J Pharmacokinet Pharmacodyn 35(4):401\u2013421","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9271_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1191\/0962280202sm293ra","volume":"11","author":"KN Berk","year":"2002","unstructured":"Berk KN, Lachenbruch PA (2002) Repeated measures with zeros. Stat Methods Med Res 11:303\u2013316","journal-title":"Stat Methods Med Res"},{"key":"9271_CR20","unstructured":"Beal SL, Sheiner LB, Boeckmann AJ (eds) (1989\u20132006) NONMEM users guides. ICON Development Solutions, Ellicott City"},{"key":"9271_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01061469","volume":"20","author":"JW Mandema","year":"1992","unstructured":"Mandema JW, Verotta D, Sheiner LB (1992) Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Pharmacodyn 20:511\u2013528","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9271_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01061662","volume":"19","author":"PO Maitre","year":"1991","unstructured":"Maitre PO, B\u00fchrer M, Thomson D, Stanski DR (1991) A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam. J Pharmacokinet Pharmacodyn 19:377\u2013384","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9271_CR23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1023\/A:1016215116835","volume":"12","author":"EI Ette","year":"1995","unstructured":"Ette EI, Ludden TM (1995) Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 12:1845\u20131855","journal-title":"Pharm Res"},{"key":"9271_CR24","doi-asserted-by":"crossref","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS,Vardarajan BN et al (2011) Common variants of MS4A4\/MS4A6E, CD2AP, CD33 and EPHA 1 are associated with late-onset Alzheimer\u2019s Disease. Nature Genetics (published online, April 3) doi: 10.1038\/ng.801","DOI":"10.1038\/ng.801"},{"issue":"4","key":"9271_CR25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jalz.2011.05.2409","volume":"8","author":"S Balsis","year":"2012","unstructured":"Balsis S, Unger AA, Benge JF, Geraci L, Doody RS (2012) Gaining precision on the Alzheimer\u2019s Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores. Alzheimer\u2019s Dementia 8(4):288\u2013294","journal-title":"Alzheimer\u2019s Dementia"},{"key":"9271_CR26","unstructured":"Ueckert S, Plan EL, Ito K, Karlsson MO, Corrigan B, Hooker AC (2012). Application of item response theory to ADAS-cog scores modelling in Alzheimer\u2019s disease. In: Annual meeting of the population approach group in Europe (PAGE), ISSN 1871-6032 PAGE 21, Abstr 2318 [ www.page-meeting.org\/?abstract=2318 ]"},{"key":"9271_CR27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","volume":"67","author":"G Meyer De","year":"2010","unstructured":"De Meyer G, Shapiro F, Vanderstichele H et al (2010) Diagnosis independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 67:949\u2013956","journal-title":"Arch Neurol"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-012-9271-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-012-9271-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-012-9271-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T09:04:04Z","timestamp":1559466244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-012-9271-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,19]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9271"],"URL":"https:\/\/doi.org\/10.1007\/s10928-012-9271-3","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,19]]}}}